Velan Capital Investment Management LP

Related Filers (15)

Other (9)

13F-HR
Wednesday, 2/14/2024
Initial Quarterly Form 13F Holdings Report filed by institutional managers
13F-HR
Monday, 11/13/2023
Initial Quarterly Form 13F Holdings Report filed by institutional managers
13F-HR
Friday, 8/11/2023
Initial Quarterly Form 13F Holdings Report filed by institutional managers
13F-HR
Monday, 5/15/2023
Initial Quarterly Form 13F Holdings Report filed by institutional managers
13F-HR
Monday, 2/13/2023
Initial Quarterly Form 13F Holdings Report filed by institutional managers
13F-HR
Monday, 11/14/2022
Initial Quarterly Form 13F Holdings Report filed by institutional managers
13F-HR
Monday, 8/15/2022
Initial Quarterly Form 13F Holdings Report filed by institutional managers
13F-HR
Monday, 5/16/2022
Initial Quarterly Form 13F Holdings Report filed by institutional managers
13F-HR
Monday, 2/14/2022
Initial Quarterly Form 13F Holdings Report filed by institutional managers
Show More

Ownership (23)

4
Friday, 2/9/2024
Jasper Therapeutics, Inc.: Statement of changes in beneficial ownership of securities
SC 13D/A
Friday, 2/9/2024
Jasper Therapeutics, Inc.: Major Shareholders
SC 13G/A
Monday, 1/29/2024
Edesa Biotech, Inc.: Major Shareholders
4
Wednesday, 10/4/2023
ALIMERA SCIENCES INC: Statement of changes in beneficial ownership of securities
4
Thursday, 8/17/2023
ALIMERA SCIENCES INC: Statement of changes in beneficial ownership of securities
SC 13D/A
Wednesday, 8/16/2023
ALIMERA SCIENCES INC: Major Shareholders
SC 13D/A
Thursday, 8/3/2023
ALIMERA SCIENCES INC: Major Shareholders
SC 13D/A
Wednesday, 6/28/2023
Praxis Precision Medicines, Inc.: Major Shareholders
SC 13D/A
Friday, 5/19/2023
ALIMERA SCIENCES INC: Major Shareholders
3
Friday, 5/19/2023
ALIMERA SCIENCES INC: Initial statement of beneficial ownership of securities
SC 13D
Friday, 3/31/2023
ALIMERA SCIENCES INC: Major Shareholders
SC 13D
Monday, 3/20/2023
Praxis Precision Medicines, Inc.: Major Shareholders
SC 13D
Monday, 2/27/2023
Jasper Therapeutics, Inc.: Major Shareholders
3
Wednesday, 2/8/2023
HERON THERAPEUTICS, INC. /DE/: Initial statement of beneficial ownership of securities
3
Friday, 2/3/2023
Jasper Therapeutics, Inc.: Initial statement of beneficial ownership of securities
SC 13G/A
Friday, 1/27/2023
Jasper Therapeutics, Inc.: Major Shareholders
SC 13G
Friday, 1/6/2023
Edesa Biotech, Inc.: Major Shareholders
SC 13D/A
Friday, 8/26/2022
Radius Health, Inc.: Major Shareholders
SC 13D/A
Tuesday, 7/12/2022
Radius Health, Inc.: Major Shareholders
SC 13D/A
Wednesday, 5/25/2022
Radius Health, Inc.: Major Shareholders
SC 13D/A
Monday, 4/18/2022
Radius Health, Inc.: Major Shareholders
SC 13D/A
Tuesday, 3/15/2022
Radius Health, Inc.: Major Shareholders
SC 13D
Monday, 3/7/2022
Radius Health, Inc.: Major Shareholders
Show More

Proxies (9)

DFAN14A
Monday, 7/11/2022
Definitive additional proxy soliciting materials filed by non-management including Rule 14(a)(12) material
DFAN14A
Friday, 6/24/2022
Definitive additional proxy soliciting materials filed by non-management including Rule 14(a)(12) material
DFAN14A
Tuesday, 6/21/2022
Definitive additional proxy soliciting materials filed by non-management including Rule 14(a)(12) material
DFAN14A
Tuesday, 6/21/2022
Definitive additional proxy soliciting materials filed by non-management including Rule 14(a)(12) material
DFAN14A
Monday, 6/13/2022
Definitive additional proxy soliciting materials filed by non-management including Rule 14(a)(12) material
DFAN14A
Tuesday, 6/7/2022
Definitive additional proxy soliciting materials filed by non-management including Rule 14(a)(12) material
DEFC14A
Monday, 6/6/2022
Definitive proxy statement in connection with contested solicitations
PRRN14A
Tuesday, 5/24/2022
Revised preliminary proxy statement filed by non-management
PREC14A
Monday, 4/18/2022
Preliminary proxy statement in connection with contested solicitations
Show More